Related Articles
Emerging targeted therapies for melanoma treatment (Review)
EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review)
Bcl-xl and Mcl-1 are the major determinants of the apoptotic response to dual PI3K and MEK blockage
BRAP2 inhibits the Ras/Raf/MEK and PI3K/Akt pathways in leukemia cells, thereby inducing apoptosis and inhibiting cell growth
The novel dual PI3K/mTOR inhibitor GDC-0941 synergizes with the MEK inhibitor U0126 in non-small cell lung cancer cells